These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
896 related items for PubMed ID: 22503564
1. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry. Stellbaum C, Ayral Y, Morguet A, Schultheiss HP, Rauch U. Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564 [Abstract] [Full Text] [Related]
2. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250 [Abstract] [Full Text] [Related]
3. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ. Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157 [Abstract] [Full Text] [Related]
4. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin. Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A. Thromb Haemost; 2007 Jul; 98(1):201-9. PubMed ID: 17598014 [Abstract] [Full Text] [Related]
5. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel. Bal Dit Sollier C, Berge N, Boval B, Dubar M, Drouet L. Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906 [Abstract] [Full Text] [Related]
10. Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Darlington A, Tello-Montoliu A, Rollini F, Ueno M, Ferreiro JL, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ. Thromb Haemost; 2014 Feb; 111(2):258-65. PubMed ID: 24154863 [Abstract] [Full Text] [Related]
11. ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay. Schäfer A, Weinberger S, Flierl U, Eigenthaler M, Störk S, Walter U, Ertl G, Bauersachs J. Thromb Haemost; 2008 Oct; 100(4):618-25. PubMed ID: 18841284 [Abstract] [Full Text] [Related]
12. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study. Ueno M, Ferreiro JL, Desai B, Tomasello SD, Tello-Montoliu A, Capodanno D, Capranzano P, Kodali M, Dharmashankar K, Charlton RK, Bass TA, Angiolillo DJ. JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495 [Abstract] [Full Text] [Related]